0001209191-21-049769.txt : 20210804
0001209191-21-049769.hdr.sgml : 20210804
20210804183427
ACCESSION NUMBER: 0001209191-21-049769
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210803
FILED AS OF DATE: 20210804
DATE AS OF CHANGE: 20210804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COLUMN GROUP III-A, LP
CENTRAL INDEX KEY: 0001668085
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40656
FILM NUMBER: 211145608
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415 8652050
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COLUMN GROUP III, LP
CENTRAL INDEX KEY: 0001668159
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40656
FILM NUMBER: 211145609
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 4158652050
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COLUMN GROUP III GP, LP
CENTRAL INDEX KEY: 0001790965
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40656
FILM NUMBER: 211145610
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 4158652050
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tenaya Therapeutics, Inc.
CENTRAL INDEX KEY: 0001858848
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 813789973
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 171 OYSTER POINT BLVD., SUITE 500
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-865-2066
MAIL ADDRESS:
STREET 1: 171 OYSTER POINT BLVD., SUITE 500
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-03
0
0001858848
Tenaya Therapeutics, Inc.
TNYA
0001790965
COLUMN GROUP III GP, LP
1 LETTERMAN DR
BLDG. D, STE. DM-900
SAN FRANCISCO
CA
94129
0
0
1
0
0001668159
COLUMN GROUP III, LP
1 LETTERMAN DRIVE
BLDG. D, STE DM-900
SAN FRANCISCO
CA
94129
0
0
1
0
0001668085
COLUMN GROUP III-A, LP
1 LETTERMAN DR
BLDG. D, STE, DM-900
SAN FRANCISCO
CA
94129
0
0
1
0
Common Stock
2021-08-03
4
C
0
4389282
0.00
A
4414720
I
See Footnote
Common Stock
2021-08-03
4
C
0
4956842
0.00
A
4985570
I
See Footnote
Series A Preferred Stock
0.00
2021-08-03
4
C
0
3727742
D
Common Stock
3727742
0
I
See Footnote
Series A Preferred Stock
0.00
2021-08-03
4
C
0
4209755
D
Common Stock
4209755
0
I
See Footnote
Series B Preferred Stock
0.00
2021-08-03
4
C
0
472659
D
Common Stock
472659
0
I
See Footnote
Series B Preferred Stock
0.00
2021-08-03
4
C
0
533781
D
Common Stock
533781
0
I
See Footnote
Series C Preferred Stock
0.00
2021-08-03
4
C
0
188881
D
Common Stock
188881
0
I
See Footnote
Series C Preferred Stock
0.00
2021-08-03
4
C
0
213306
D
Common Stock
213306
0
I
See Footnote
The securities are directly held by The Column Group III, LP ("TCG III LP"). The Column Group III GP, LP ("TCG III GP") is the general partner of TCG III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are David Goeddel, a member of the Issuer's board of directors, Peter Svennilson and Tim Kutzkey (collectively, the "Managing Partners"). The Managing Partners may be deemed to share voting and investment power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.
The securities are directly held by The Column Group III-A, LP ("TCG III-A LP"). TCG III GP is the general partner of TCG III-A LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are the Managing Partners. The Managing Partners may be deemed to share voting and investment power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.
Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock will automatically convert into one share of common stock immediately prior to the completion of the Issuer's initial public offering, and has no expiration date.
The Column Group III GP, LP /s/James Evangelista, Attorney-in-Fact
2021-08-03
The Column Group III, LP by The Column Group III GP, LP, its general partner /s/ James Evangelista Attorney-in-Fact
2021-08-03
The Column Group III-A, LP. by The Column Group III GP, LP, its general partner /s/ James Evangelista Attorney-in-Fact
2021-08-03